跳至主要内容
临床试验/JPRN-jRCT1080223989
JPRN-jRCT1080223989招募中Unknown

Identification of biomarkers for response to anti-VEGF treatment in patients with diabetic macular edema

SANTEN PHARMACEUTICAL CO., LTD.0 个研究点目标入组 36 人开始时间: 2018年7月30日最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 21age old 至 ot applicable(—)
性别
All

入选标准

  • 1) 21 years old or older
  • 2) Diagnosis of diabetes mellitus with diabetic macular edema
  • 3) BCVA (best corrected visual acuity) less than or equal to 20/32
  • 4) Central subfield thickness on OCT (optical coherence tomography) greater than or equal to 340 um

排除标准

  • 1) Renal failure requiring hemodialysis or peritoneal dialysis
  • 2) Macular edema due to a cause other than DME (diabetic macular edema)
  • 3) Ocular condition which might affect macular edema during the course of the study
  • 4) History of systemic or ocular anti-VEGF treatment within 6 months
  • 5) History of major ocular surgery within 6 months
  • 6) History of intravitreal steroids within 6 months

研究者

相似试验